Nova Eye Medical Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser; 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degeneration for the treatment of retinal disease. The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in patients glaucoma; iTrack Advance; and Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.
Key Metrics
PE ratio
-
PB ratio
2.61
Dividend yield
-
Beta
0.89
Market cap
$49.85M
Enterprise value
$47.79M
Company profile
| Industry / Sector | Medical Devices / Healthcare |
|---|---|
| Website | https://www.nova-eye.com |
| Mailing address | 107 Rundle Street Kent Town SA 5067 Australia |
| Phone / Fax | 61 8 8362 0193 / 61 8 8362 0193 |
Dividends
More: Nova Eye Medical Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Nova Eye Medical paid $- dividend and the ex-dividend date was 21 Jul 2020.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.EYE dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Nova Eye Medical.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Victor Previn | Founder & Executive Chairman | 67 | |
| Mr. Thomas H. Spurling AM, BSc (Hons), FRACI, FTSE, Ph.D. | MD & Executive Director | 63 | |
| Ms. Kimberley Menzies | Chief Financial Officer | ||
| Mark Flynn | Investor Relations | ||
| Ms. Kate Hunt | Chief Commercial Officer | ||
| Mr. Joe Bankovich | President of Global Sales | ||
| Mr. Joaquin V. Wolff | President of Ellex iTrack | 67 | |
| Mr. Simon Jeremy Newton Gray BEc, C.A. | Company Secretary | 66 | |
| Jordan Possingham | Financial Controller | ||
| Mr. Don Watton | Vice President of Global Service |
Profitability and management effectiveness
Profit margin
-30.95%
Operating margin
-22.02%
Return on assets
-19.92%
Return on equity
-44.96%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Nova Eye Medical is 49.85M and its enterprise value is 47.79M. The enterprise value to revenue ratio of EYE is 1.63. The enterprise value to EBITDA ratio of EYE is -7.11.
The EYE's stocks Beta value is 0.89 making it 11% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Nova Eye Medical (EYE)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Nova Eye Medical (ASX:EYE) Frequently Asked Questions
1. What is Nova Eye Medical's Stock Symbol?
Nova Eye Medical trades on ASX under the ticker symbol "EYE".
2. What is Nova Eye Medical's stock price today?
One share of EYE stock can currently be purchased for approximately $0.175.
3. How can I contact Nova Eye Medical?
Nova Eye Medical's mailing address is 107 Rundle Street Kent Town SA 5067 Australia. The company can be reached via phone at 61 8 8362 0193.
4. What is Nova Eye Medical's official website?
The official website of Nova Eye Medical is https://www.nova-eye.com.